MBP (85-106) guinea pig, MBP (86-107), human – 1 mg

Overview

The MBP (85-106) guinea pig and MBP (86-107) human peptides are crucial tools for researchers investigating multiple sclerosis and related neurological conditions. These peptides represent a specific fragment of the myelin basic protein (MBP), which plays a significant role in myelin sheath formation and maintenance. Understanding the properties of MBP is essential for exploring its implications in demyelination diseases, making these peptides indispensable for your research needs.

Key Features

• Designed for research on multiple sclerosis and related conditions.
• Sequence: Guinea pig MBP (85-106) and human MBP (86-107).
• High-quality peptides with verified purity for reliable results.
• Available in 1 mg quantities, suitable for various experimental applications.
• Backed by AnaSpec’s commitment to research excellence and product reliability.

Specifications

FAQ

What is the origin of the MBP peptides?

The MBP (85-106) peptide is derived from guinea pigs, while the MBP (86-107) peptide corresponds to a segment from human myelin basic protein. Both are essential for studying the biology of myelin and its role in neurological disorders.

How can I use these peptides in my research?

These peptides can be utilized in various assays to study the immunological responses related to multiple sclerosis. Researchers often employ them in binding studies, immunogenicity assessments, and development of therapeutic approaches.

What is the purity level of the peptides?

Our peptides, including MBP (85-106) and MBP (86-107), are manufactured with high purity standards, ensuring reliability and reproducibility in research outcomes.

To support your related projects, consider exploring our PKG Substrateor our selection of other peptides available for diverse applications. Equip your lab with our top-tier products and contribute to groundbreaking research in the field.

Related Products

• Autocamtide-2 [KKALRRQETVDAL]
• CREBtide [KRREILSRRPSYR], 5-FAM labeled